SCHEMBL1967057

SCHEMBL1967057

CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(c3ccccc3)c3ccccc3)CC2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 5/20 0.73
LMNA P02545 4/20 0.73
DRD3 P35462 4/20 0.73
KCNH2 Q12809 4/20 0.73
HTR2A P28223 3/20 0.73
HTR2B P41595 3/20 0.73
BLM P54132 2/20 0.73
CNR1 P21554 1/20 0.73
APEX1 P27695 1/20 0.73
PDE4A P27815 1/20 0.73
PDE3A Q14432 1/20 0.73
DRD2 P14416 3/20 0.71
ALOX15 P16050 1/20 0.71
HSD17B10 Q99714 1/20 0.71
SLC6A4 P31645 4/20 0.57
SLC6A3 Q01959 4/20 0.57
SLC6A2 P23975 3/20 0.57
NPC1 O15118 2/20 0.57
EGFR P00533 2/20 0.57
FYN P06241 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6451132 0.89 HRH1 (0.59) HRH1LMNADRD3KCNH2HTR2A
SCHEMBL27420591 0.87 HRH1 (0.69) HRH1LMNADRD3KCNH2HTR2A
SCHEMBL1973484 0.86 LMNA (0.55) HRH1LMNADRD3KCNH2HTR2A
SCHEMBL9074777 0.85 HTR2A (0.56) HRH1LMNADRD3KCNH2HTR2A
SCHEMBL1968089 0.85 LMNA (0.69) HRH1LMNADRD3KCNH2HTR2A
Fexofenadine SCHEMBL1561082 0.84 HRH1 (1.00) HRH1LMNADRD3KCNH2HTR2A
Fexofenadine SCHEMBL1972366 0.84 HRH1 (1.00) HRH1LMNADRD3KCNH2HTR2A
Fexofenadine SCHEMBL3178320 0.84 HRH1 (1.00) HRH1LMNADRD3KCNH2HTR2A
SCHEMBL11383896 0.84 LMNA (0.62) HRH1LMNADRD3KCNH2HTR2A
Fexofenadine SCHEMBL4900 0.84 HRH1 (1.00) HRH1LMNADRD3KCNH2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476445-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2013-07-02 US disclosed
US-20110295014-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2011-12-01 US disclosed
US-8022220-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2011-09-20 US disclosed
EP-1958935-B1 Process for the production of terfenadine and carebastine derivatives with microorganisms ALBANY MOLECULAR RES INC (US) 2011-06-22 EP disclosed
US-20100137605-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed
US-7691615-B2 Process for the production of piperidine derivatives with microorganisms ALBANY MOLECULAR RESEARCH, INC. (US) 2010-04-06 US disclosed
US-7678915-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2010-03-16 US disclosed
US-20100010227-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2010-01-14 US disclosed
US-7560561-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2009-07-14 US disclosed
EP-1339864-B1 PROCESS FOR THE PRODUCTION OF PIPERIDINE DERIVATIVES WITH MICROORGANISMS AMR TECHNOLOGY INC (US) 2008-12-31 EP disclosed
WO-1997023213-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 1997-07-03 WO disclosed
US-5589487-A Piperidine derivatives and process for their production ALBANY MOLECULAR RESEARCH, INC. (US) 1996-12-31 US disclosed
US-5581011-A Aromatic ketones and processes for their preparation ALBANY MOLECULAR RESEARCH, INC. (US) 1996-12-03 US disclosed
US-5578610-A Piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 1996-11-26 US disclosed
EP-0723958-A1 Synthesis of substantially pure terfenadine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 1996-07-31 EP disclosed
EP-0703902-A4 ALBANY MOLECULAR RES INC (US) 1996-04-10 EP disclosed
EP-0703902-A1 PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION ALBANY MOLECULAR RESEARCH, INC. (US) 1996-04-03 EP disclosed
WO-1995000482-A1 PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION ALBANY MOLECULAR RESEARCH, INC. (US) 1995-01-05 WO disclosed
US-4285957-A ANTIALLERGENS; ANTIHISTAMINES; BRONCHODILATOR AGENTS RICHARDSON-MERRELL INC. (US) 1981-08-25 US disclosed
US-4254129-A ANTIALLERGENS, BRONCHODILATORS, ANTIHISTAMINES; 4-DIPHENYLMETHYL PIPERIDINO-ALKANOLS RICHARDSON-MERRELL INC. (US) 1981-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295014-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES OR10J3, NR1H2, NR1H3 HRH1 313/4885LMNA 4284/4885DRD3 448/4885
US-20100137605-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES HPD, PTMA, HAAO HRH1 727/4885LMNA 2264/4885DRD3 687/4885
US-20100010227-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES DDC, HPD, ALDH7A1 HRH1 882/4885LMNA 2378/4885DRD3 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.